Wednesday, November 30, 2011

Watson Launches authorized Generics for atorvastatin

Watson Pharmaceuticals, Inc. has launched an authorized generic version of LIPITOR®(atorvastatin calcium tablets) as part of an exclusive agreement with Pfizer Inc. Watson began shipping the product today. 
Under the terms of the exclusive supply and distribution agreement, Pfizer manufactures and supplies Watson with all dosage strengths of the authorized generic product. Watson markets and distributes the product in the United States. Pfizer will receive a share of the net sales from Watson's sales of the product. The agreement runs until November 30, 2016

2 comments:

  1. Would this impact Ranbaxy 180-days exclusivity?

    ReplyDelete
  2. Since watson has launched, it implies Ranbaxy will also launch. As per law, no generic player can launch unless the FTF player launches, which in this case is Ranbaxy.

    ReplyDelete